Indole-derived heterocyclic compounds that inhibit wnk1.
CL202602076A1Pending Publication Date: 2026-08-21DANIA THERAPEUTICS APS
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202602076
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-10
- Filing Date
- 2026-06-18
- Publication Date
- 2026-08-21
Abstract
This application relates to compounds of formula (I), pharmaceutical compositions comprising such compounds, and their use for treating, alleviating, or preventing diseases or disorders related to WNK1 activity.
Need to check novelty before this filing date? Find Prior Art